Hospitalization risk in patients with schizophrenia before and after initiation of risperidone long-acting injection in Japan.
Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan. Electronic address: hajime-greentea@hotmail.co.jp.
Bunta
B
Yoshimura
Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan.
Ikuta
I
Shinkawa
Department of Psychiatry, Okayama Psychiatric Medical Center, Okayama, Japan.
Akiko
A
Konishi
D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D005260:Female; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D011618:Psychotic Disorders / Q000188:drug therapy; D012189:Retrospective Studies; D012307:Risk Factors; D018967:Risperidone / Q000008:administration & dosage*; D012559:Schizophrenia / Q000188:drug therapy*; D055815:Young Adult
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018967:Risperidone
Hospitalization; Risperidone long-acting injection; Schizophrenia